3-o-methyl-l-dopa

3-O-Methyldopa (3-OMD) is the primary metabolite of L-DOPA formed by COMT. It serves as a clinical biomarker in Parkinson's disease research to monitor L-DOPA metabolism and pharmacological response.

3-O-methyl-L-DOPA is a metabolite of L-DOPA , produced by the activity of catechol O-methyltransferase. 3-O-methyl-L-DOPA may have effects of its own or it may compete with the actions of L-DOPA.

Nebicapone is a reversible catechol-O-methyltransferase (COMT) inhibitor and is mainly metabolized by glucuronidation. Nebicapone is mainly peripherally acting inhibitor that decreases the biotransformation of L-DOPA to 3-O-methyl-DOPA by inhibition of CO

3-Methoxy-L-tyrosine-D3 monohydrate is a deuterated compound of 3-Methoxy-L-tyrosine monohydrate. 3-Methoxy-L-tyrosine monohydrate (T36122) has a CAS number of 200630-46-2. 3-O-methyl-L-DOPA is a metabolite of L-DOPA , produced by the activity of catechol O-methyltransferase. 3-O-methyl-L-DOPA may have effects of its own or it may compete with the actions of L-DOPA.

L-3-O-Methyl-Dopa-[D3] H2O (Standard) is a reference standard of L-3-O-Methyl-Dopa-[D3] H2O intended for quantitative analysis, quality control, and related biochemical research applications.